Cell Cycle

List of Papers (Total 5,062)

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans.

Notch pathway regulates female germ cell meiosis progression and early oogenesis events in fetal mouse.

Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications.

miR-34a is essential for p19(Arf)-driven cell cycle arrest.

Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.

Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.

The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation.

Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.

De novo fatty acid synthesis at the mitotic exit is required to complete cellular division.

Basis of Treg development in the thymus.

microRNA-17~92 is a powerful cancer driver and a therapeutic target.

Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition.

Characterization of contracting cardiomyocyte colonies in the primary culture of neonatal rat myocardial cells: a model of in vitro cardiomyogenesis.

Watching a DNA polymerase in action.

The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation.

JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.

miR-888: hit it when you see it!

Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear.

Revisiting p53 for cancer-specific chemo- and radiotherapy: ten years after.

The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle.

GSK-3β: a key regulator of breast cancer drug resistance.

Complete senescence: RB and PML share the task.

Intramembrane cleaving proteases (I-CLiPs) as guardians of shuttling proteins.

Cell-size control: complicated.